Incidence rate of adverse drug reactions during long-term follow-up of patients newly treated with amiodarone

American Journal of Therapeutics

Volumn 13, Issue 4, 2006, Pages 315-319

  Bongard, Vanina ^a   Marc, Delay ^b   Philippe, Vigreux ^a   Jean Louis, Montastruc ^a   Maryse, Lapeyre Mestre ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b Hôpitaux de Toulouse   (France)

Author keywords

Adverse drug reactions; Amiodarone; Follow up study; Hyperthyroidism; Hypothyroidism; Pneumonitis

Indexed keywords

AMIODARONE;

AGED; ARTICLE; BRADYCARDIA; COHORT ANALYSIS; CONFIDENCE INTERVAL; DRUG FATALITY; DRUG SURVEILLANCE PROGRAM; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HEART ARRHYTHMIA; HEART BLOCK; HEART DISEASE; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; INCIDENCE; INTERSTITIAL PNEUMONIA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OUTPATIENT; PERIPHERAL NEUROPATHY; PHOTOSENSITIVITY; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STORAGE DISEASE; THYROID DISEASE; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; TREMOR;

ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; FRANCE; HEART DISEASES; HUMANS; HYPOTHYROIDISM; MALE; OUTPATIENTS; PHOTOSENSITIVITY DISORDERS;

EID: 33749352304     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045391-200607000-00007     Document Type: Article

References (20)

1. Greene HL, Roden DM, Katz RJ, et al. The Cardiac Arrhythmia Suppression Trial: first CAST then CAST II. J Am Coll Cardiol. 1992;19:894-898.
2. Coplen SE, Antman EM, Berlin JA, et al. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials. Circulation. 1990;82:1106-1116.
3. Morganroth J, Goin JE. Quinidine-related mortality in the short-to-medium-term treatment of ventricular arrhythmias. A meta-analysis. Circulation. 1991;84:1977-1983.
4. Amiodarone Trials Meta-Analysis Investigators. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trails. Lancet. 1997;350:1417-1424.
5. Podrid PJ. Amiodarone: reevaluation of an old drug. Ann Intern Med. 1995;122:689-700.
6. Connolly SJ. Evidence-based analysis of amiodarone efficacy and safety. Circulation. 1999;100:2025-2034.
7. Adams PC, Holt DW, Storey GC, et al. Amiodarone and its desethyl metabolite: tissue distribution and morphologic changes during long-term therapy. Circulation. 1985;72:1064-1075.
8. Newman CM, Price A, Davies DW, et al. Amiodarone and the thyroid: a practical guide to the management of thyroid dysfunction induced by amiodarone therapy. Heart. 1998;79:121-127.
9. Martino E, Safran M, Aghini-Lombardi F, et al. Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy. Ann Intern Med. 1984;101:28-34.
10. Venulet J, Ten Ham M. Methods for monitoring and documenting adverse drug reactions. Int J Clin Pharmacol Ther. 1996;34:112-129.
11. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356:1255-1259.
12. Albert SG, Alves LE, Rose EP. Thyroid dysfunction during chronic amiodarone therapy. J Am Coll Cardiol. 1987;9:175-183.
13. Nademanee K, Piwonka RW, Singh BN, et al. Amiodarone and thyroid function. Progr in Cardiovasc Dis. 1989;31:427-437.
14. Trip MD, Wiersinga W, Plomp TA. Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism. Am J Med. 1991;91:507-511.
15. Harjai KJ, Licata AA. Effects of amiodarone on thyroid function. Ann Intern Med. 1997;126:63-73.
16. Bartalena L, Brogioni S, Grasso L, et al. Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study. J Clin Endocrinol Metab. 1996;81:2930-2933.
17. Klein I, Ojamaa K. Mechanisms of disease: thyroid hormone and the cardiovascular system. New Engl J Med. 2001;344:501-509.
18. Vandergheynst F, Lienart F, Ducobu J. Amiodarone and thyroid disorders. Prospective study and review of the literature. Rev Med Brux. 1999;20:411-417.
19. Bagheri H, Lapeyre-Mestre M, Levy C, et al. Dysthyroidism due to amiodarone: comparison of spontaneous reporting in Aquitaine, Midi-Pyrénées and Languedoc-Roussillon. Therapie. 2001;56:301-306.
20. Vorperian VR, Havighurst TC, Miller S, et al. Adverse effects of low dose amiodarone: a meta-analysis. J Am Coll Cardiol. 1997;30:791-798.